e-Therapeutics PLC (LSE:ETX) - Share price - Overview

Stock Report

e-Therapeutics PLC ETX

Last Price
GBX7.10

Day Change
0.00|0.00%

As of 19/07/2018
12:54:47 BST | GBX
Minimum 15 Minutes Delay.

Last Close7.10p
Day Range7.05 - 7.05
Mkt Cap19.07Mil
52-Wk Range6.70 - 12.20
Yield %-
ISINGB00B2823H99
Volume67,000
P/E-3.55
P/SInfinity
P/CF-0.04

Share Price

Total Returns 19/07/2018

 Chg (%)  
More ...
e-Therapeutics PLC-3.73 
FTSE 100 TR GBP0.80
 
Financials
201620172018
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-11.56-14.23-6.77
Net Profit-8.82-13.13-5.36
Reported EPS-3.34-4.91-2.00
Balance Sheet
Current Assets28.7817.7211.56
Non Current Assets0.800.210.21
Total Assets29.5917.9311.76
Current Liabilities1.161.951.02
Total Liabilities1.161.951.02
Total Equity28.4315.9810.74
Cash Flow
Operating Cash Flow-11.20-12.01-7.37
Net Change in Cash4.52-1.872.62

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/07/2018PurchaseProfessor Trevor Mervyn Jones CBE7.3874,5265,500.00
08/01/2018PurchaseProfessor Trevor Mervyn Jones CBE9.2559,4605,500.00
15/12/2017PurchaseMr. Iain Gladstone Ross8.90200,00017,800.00
15/12/2017PurchaseMs. Christine Helen Soden8.90120,00010,680.00

Company Profile

e-Therapeutics PLC is a drug discovery company. The company's discovery platform is based on the network of pharmacology and chemical biology. e-Therapeutics operates in a segment of drug discovery and development.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 26/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-63.03
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorProfessor Trevor Mervyn Jones CBE
Executive Director, ChairmanMr. Iain Gladstone Ross
Non-Executive DirectorMs. Christine Helen Soden
Executive Director, Finance Director and Interim COOMr. Steven Medlicott
Executive Director, Chief Executive OfficerDr. Raymond John Barlow
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.